Effect of Muscle Energy Technique Versus Myofascial Release on Cervical and Lumbar Pain

March 5, 2024 updated by: Samar Ahmed Abd EL Salam Negm, Cairo University

Effect of Muscle Energy Technique Versus Myofascial Release on Cervical and Lumbar Pain in Premenopausal Women With Fibromyalgia

The aim of the study is to determine the effect of muscle energy technique versus myofascial release on cervical and lumbar pain in premenopausal women with fibromyalgia

Study Overview

Detailed Description

Fibromyalgia is an idiopathic, non articular pain syndrome with generalized tender points. It is multisystem disease characterized by sleep disturbance and fatigue. It affect 5% of the world population. The incidence is higher in women than in men. And the age is between 30 and 35 years old.

Study Type

Interventional

Enrollment (Actual)

74

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Premenopausal women with fibromyalgia
  • Ages ranges between 30 - 45 years old
  • Body mass index < 35 kg/m2
  • All are medically stable

Exclusion Criteria:

  • specific cervical and lumbar pain
  • Smokers
  • Pregnant women
  • Medically unstable
  • Postmenopausal women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Myofascial release
The patients will receive myofascial release technique on cervical and lumbar regions three times per week for four weeks
Is Facilitation of mechanical and neurological adaptive capacity as integrated through the Myofascial system
Experimental: Muscle energy technique
The patients will receive muscle energy technique for cervical and lumbar regions three times per week for four weeks
Is manual therapy procedure that involves alternating periods of resisted muscle contraction and assisted stretching

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Active range of motion of cervical and lumbar regions
Time Frame: Four weeks
Measurement of active flexion, extension, lateral flexion in cervical and lumbar regions before and after the treatment
Four weeks
Fibromyalgia impact questionnaire
Time Frame: Four weeks
Used to assess health related quality of life before and after the treatment, maximum score means worse outcome
Four weeks
Visual analogue scale
Time Frame: Four weeks
Used to assess the severity of cervical and lumbar pain of each premenopausal women in both groups before and after the treatment, maximum score means worse outcome
Four weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

June 1, 2023

Study Completion (Actual)

July 1, 2023

Study Registration Dates

First Submitted

March 14, 2023

First Submitted That Met QC Criteria

March 14, 2023

First Posted (Actual)

March 27, 2023

Study Record Updates

Last Update Posted (Estimated)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 012/004046

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Pain

Clinical Trials on Myofascial release

Subscribe